The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III study of APF530 versus ondansetron with a neurokinin 1 antagonist + corticosteroid in preventing highly emetogenic chemotherapy-induced nausea and vomiting: MAGIC trial.
 
Ian D. Schnadig
Employment - Compass Oncology
Leadership - Compass Oncology
Consulting or Advisory Role - HERON; Tesaro
Travel, Accommodations, Expenses - McKesson; Tesaro
 
Richy Agajanian
No Relationships to Disclose
 
Shaker R. Dakhil
Research Funding - HERON
 
Nashat Y. Gabrail
Speakers' Bureau - Boehringer Ingelheim; Janssen; Onyx; Sanofi
Research Funding - Karyopharm Therapeutics (Inst)
 
Robert E. Smith
Honoraria - Cardinal Health; Genentech; Myriad Pharmaceuticals
Consulting or Advisory Role - Cardinal Health
Research Funding - HERON
Travel, Accommodations, Expenses - Cardinal Health; Genentech; Myriad Pharmaceuticals
 
Charles W. Taylor
No Relationships to Disclose
 
Sharon Wilks
Speakers' Bureau - Genentech; Pfizer
 
William Cooper
Employment - TFS
Stock and Other Ownership Interests - Amgen; Bristol-Myers Squibb; Lilly; Merck; Pfizer
Consulting or Advisory Role - TFS
 
Michael Mosier
Consulting or Advisory Role - EMB Statistical Solutions
 
Yvette Payne
Employment - HERON
Stock and Other Ownership Interests - HERON
 
Michael Klepper
Employment - Druggablity Technologies
Leadership - Druggablity Technologies
Stock and Other Ownership Interests - Druggablity Technologies
Consulting or Advisory Role - HERON; Ocata Therapeutics; Onconova Therapeutics
Travel, Accommodations, Expenses - HERON; Onconova Therapeutics
 
Jeffrey L. Vacirca
Stock and Other Ownership Interests - AmerisourceBergen; HERON; Spectrum Pharmaceuticals
Honoraria - Spectrum Pharmaceuticals
Consulting or Advisory Role - HERON
Speakers' Bureau - Dendreon; Spectrum Pharmaceuticals